InsidersTradesSigma
Track the 앱클론 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 앱클론 has logged 6 reports. The latest transaction was filed on 5 October 2022 (Sale). Among the most active insiders: 쿼드자산운용. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
AppClone is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative technologies and solutions for the medical sector.